The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and ...

This new Liraglutide injection is a generic equivalent for Victoza, which is a once-daily noninsulin medicine that lowers ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Find insight on Hims & Hers, U.K. pharmaceutical stocks, Novo Nordisk, AstraZeneca and more in the latest Market Talks ...

Meitheal Pharmaceuticals recently launched two new generics. The company released alprostadil injection 500 mcg/ml single-dose vials to the U.S. market, where only an ampoule form is offered. The ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

Lexaria Bioscience (LEXX) announced that dosing has begun as scheduled in its human study GLP-1-H25-5 that is comparing oral ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.